Table 4 Results of subjective image quality analysis
Parameter | Fixed dose protocol (n = 50) | Cohen’s κ | LBW protocol (n = 50) | Cohen’s κ | p value |
|---|---|---|---|---|---|
Arterial hepatic enhancement | 4 (2–5) | 0.73 (95% CI 0.55–0.90) | 4 (2–5) | 0.71 (95% CI 0.54–0.88) | 0.396 |
PVP hepatic enhancement | 5 (3–5) | 0.84 (95% CI 0.72–0.96) | 5 (3–5) | 0.80 (95% CI 0.60–1.00) | 0.365 |
Arterial pancreatic enhancement | 4 (2–5) | 0.75 (95% CI 0.61–0.88) | 4 (3–5) | 0.88 (95% CI 0.71–1.00) | 0.696 |
PVP pancreatic enhancement | 4 (3–5) | 0.90 (95% CI 0.80–1.00) | 4 (3–5) | 0.91 (95% CI 0.78–1.00) | 0.659 |
Arterial renal enhancement | 4 (3–5) | 0.94 (95% CI 0.86–1.00) | 4 (3–5) | 0.97 (95% CI 0.91–1.00) | 0.311 |
PVP renal enhancement | 4 (3–5) | 0.72 (95% CI 0.53–0.90) | 4 (3–5) | 0.94 (95% CI 0.86–1.00) | 0.213 |